The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial

Bernd Froessler, Peter Palm, Ingo Weber, Nicolette A Hodyl, Rajvinder Singh, Elizabeth M Murphy, Bernd Froessler, Peter Palm, Ingo Weber, Nicolette A Hodyl, Rajvinder Singh, Elizabeth M Murphy

Abstract

Objective: To determine if preoperative intravenous (IV) iron improves outcomes in abdominal surgery patients.

Summary background data: Preoperative iron deficiency anemia (IDA) occurs frequently; however if left untreated, increases the risk of blood transfusion allogeneic blood transfusion (ABT). Limited evidence supports IDA treatment with preoperative IV iron. This randomized controlled trial aimed to determine whether perioperative IV iron reduced the need for ABT.

Methods: Between August 2011 and November 2014, 72 patients with IDA were assigned to receive either IV iron or usual care. The primary endpoint was incidence of ABT. Secondary endpoints were various hemoglobin (Hb) levels, change in Hb between time points, length of stay, iron status, morbidity, mortality, and quality of life 4 weeks postsurgery.

Results: A 60% reduction in ABT was observed in the IV iron group compared with the usual care group (31.25% vs 12.5%). Hb values, although similar at randomization, improved by 0.8 g/dL with IV iron compared with 0.1 g/dL with usual care (P = 0.01) by the day of admission. The IV iron group had higher Hb 4 weeks after discharge compared with the usual care group (1.9 vs 0.9 g/dL, P = 0.01), and a shorter length of stay (7.0 vs 9.7 d, P = 0.026). There was no difference in discharge Hb levels, morbidity, mortality, or quality of life.

Conclusions: Administration of perioperative IV iron reduces the need for blood transfusion, and is associated with a shorter hospital stay, enhanced restoration of iron stores, and a higher mean Hb concentration 4 weeks after surgery.

Conflict of interest statement

The author reports no conflicts of interest.

References

    1. McLean E, Cogswell M, Egli I, et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 2009; 12:444–454.
    1. Beattie WS, Karkouti K, Wijeysundera DN, et al. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110:574–581.
    1. Hamilton W, Lancashire R, Sharp D, et al. The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records. Br J Cancer 2008; 98:323–327.
    1. Browning RM, Trentino K, Nathan EA, et al. Preoperative anaemia is common in patients undergoing major gynaecological surgery and is associated with a fivefold increased risk of transfusion. Aust N Z J Obstet Gynaecol 2012; 52:455–459.
    1. Hreinsson JP, Jonasson JG, Bjornsson ES. Bleeding-related symptoms in colorectal cancer: a 4-year nationwide population-based study. Aliment Pharmacol Ther 2014; 39:77–84.
    1. Gupta PKMD, Sundaram AMMPH, MacTaggart JNMD, et al. Preoperative anemia is an independent predictor of postoperative mortality and adverse cardiac events in elderly patients undergoing elective vascular operations. Ann Surg 2013; 258:1096–1102.
    1. Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:47–52.
    1. Sanders J, Keogh BE, Van der Meulen J, et al. The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery. J Clin Epidemiol 2012; 65:423–433.
    1. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 2012; 256:235–244.
    1. Ferraris VA, Davenport DL, Saha SP, et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147:49–55.
    1. Glance LG, Dick AW, Mukamel DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114:283–292.
    1. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4:CD002042.
    1. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409–417.
    1. National Blood Authority. Patient blood management guidelines: Module 2 —Perioperative. 2012. Available at: Accessed August 15, 2015
    1. Leal-Noval SR, Munoz M, Asuero M, et al. Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the “Seville Document”. Blood Transfus 2013; 11:585–610.
    1. Gombotz H, Rehak PH, Shander A, et al. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 2014; 54:2646–2657.
    1. Munoz M, Gomez-Ramirez S, Campos A, et al. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood Transfus 2015; 1–10.
    1. Shander A. Preoperative anemia and its management. Transfus Apher Sci 2014; 50:13–15.
    1. Froessler B, Papendorf D. Intravenous iron sucrose—an effective and attractive modality for perioperative anaemia management. Anaesth Intensive Care 2010; 38:960–962.
    1. Okuyama M, Ikeda K, Shibata T, et al. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today 2005; 35:36–40.
    1. Muñoz M, Breymann C, García-Erce JA, et al. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008; 94:172–183.
    1. Froessler B, Tufanaru C, Cyna A, et al. Preoperative anaemia management with intravenous iron: a systematic review. JBI Database Syst Rev Implement Rep 2013; 11:33.
    1. Gasche C. Intravenous iron in inflammatory bowel disease. Semin Hematol 2006; 43:S18–S22.
    1. Lachance K, Savoie M, Bernard M, et al. Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother 2011; 45:764–770.
    1. Schroder O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005; 100:2503–2509.
    1. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13:1545–1553.
    1. Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood Transfus 2014; 12:296–300.
    1. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473–483.
    1. Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004; 40:2293–2306.
    1. Dallman PR. Iron deficiency: does it matter? J Intern Med 1989; 226:367–372.
    1. Isbister JP, Shander A, Spahn DR, et al. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev 2011; 25:89–101.
    1. Tinmouth A, Macdougall L, Fergusson D, et al. Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians’ transfusion practices. Arch Intern Med 2005; 165:845–852.
    1. Isbister JP. The three-pillar matrix of patient blood management. ISBT Sci Series 2015; 10:286–294.
    1. Bolton-Maggs PH, Cohen H. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol 2013; 163:303–314.
    1. Kickler TS, Smith B, Bell W, et al. Estimation of transfused red cell survival using an enzyme-linked antiglobulin test. Transfusion 1985; 25:401–405.
    1. Muñoz M, Gómez-Ramírez S, Martín-Montañez E, et al. Perioperative anemia management in colorectal cancer patients: a pragmatic approach. World J Gastroenterol 2014; 20:1972–1985.
    1. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378:1396–1407.
    1. Theusinger OM, Felix C, Spahn DR. Strategies to reduce the use of blood products: a European perspective. Curr Opin Anaesthesiol 2012; 25:59–65.
    1. Abdelsattar ZMMDM, Hendren SMDMPH, Wong SLMDMS, et al. Variation in transfusion practices and the effect on outcomes after noncardiac surgery. Ann Surg 2015; 262:1–6.
    1. Isbister JP. Strategies for avoiding or minimizing homologous blood transfusion: a sequel to the AIDS scare. Med J Aust 1985; 142:596–599.
    1. Spahn DR, Theusinger OM, Hofmann A. Patient blood management is a win-win: a wake-up call. Br J Anaesth 2012; 108:889–892.
    1. Spahn DR, Zacharowski K. Non-treatment of preoperative anaemia is substandard clinical practice. Br J Anaesth 2015.
    1. Shander A, Goodnough LT, Javidroozi M, et al. Iron deficiency anemia-bridging the knowledge and practice gap. Transfus Med Rev 2014; 28:156–166.
    1. Munoz M, Gomez-Ramirez S, Kozek-Langeneker S, et al. ’Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients. Br J Anaesth 2015; 115:15–24.
    1. Frank SM, Ejaz A, Pawlik TM. Blood transfusion strategy and clinical outcomes. Ann Surg 2015; 262:7–8.
    1. Beris P, Munoz M, Garcia-Erce JA, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100:599–604.
    1. Munoz M, Gomez-Ramirez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2014; 54:289–299.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren